Biotech · Public company · Miami, FL, US
Opko Health, Inc.
Ticker OPK · SEC CIK 0000944809
Track this companyFree. Adds Opko Health, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials252 recruiting or active
Pipeline programs34From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline34
- CTAP101Phase 3 · Chronic Kidney Disease stage3ClinicalTrials.gov · fetched Nov 12, 2026
- MOD-4023Phase 3 · Pediatric Growth Hormone DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- SomatropinPhase 3 · Pediatric Growth Hormone DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- Calcifediol Oral CapsulePhase 2 · Secondary Hyperparathyroidism Due to Renal CausesClinicalTrials.gov · fetched Nov 12, 2026
- CTAP101Phase 2 · CKD Stage 3ClinicalTrials.gov · fetched Nov 12, 2026
- ELND005Phase 2 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ELND005Phase 2 · Down SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- ELND005Phase 2 · Bipolar 1 DisorderClinicalTrials.gov · fetched Nov 12, 2026
- ELND005Phase 2 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ELND005 (scyllo-inositol)Phase 2 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Exenatide extended-releasePhase 2 · Diabetes Mellitus, Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- Group 1 ELND005Phase 2 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Group 2 ELND005Phase 2 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Group-1 (15mg, OPK-88004)Phase 2 · Benign Prostatic HyperplasiaClinicalTrials.gov · fetched Nov 12, 2026
- Group-2 (25 mg,OPK-88004)Phase 2 · Benign Prostatic HyperplasiaClinicalTrials.gov · fetched Nov 12, 2026
- LamotriginePhase 2 · Bipolar 1 DisorderClinicalTrials.gov · fetched Nov 12, 2026
- LY2944876Phase 2 · Diabetes Mellitus, Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- MetforminPhase 2 · Diabetes Mellitus, Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- MOD-4023Phase 2 · Growth Hormone Deficiency (GHD)ClinicalTrials.gov · fetched Nov 12, 2026
- OPK-88003Phase 2 · Type 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- OPK-88006Phase 2 · MASHClinicalTrials.gov · fetched Nov 12, 2026
- RayaldeePhase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- Valproic acidPhase 2 · Bipolar 1 DisorderClinicalTrials.gov · fetched Nov 12, 2026
- CTAP101 CapsulesPhase 1 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- CTAP101 CapsulesPhase 1 · Vitamin D InsufficiencyClinicalTrials.gov · fetched Nov 12, 2026
- E1 and G1Phase 1 · Type 2 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- E1 and G1Phase 1 · Type 1 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- MOD-4023Phase 1 · Growth Hormone DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- MOD-5014Phase 1 · Hemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- SomatrogonPhase 1 · Healthy Male VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- Calcifediol Oral ProductSecondary Hyperparathyroidism Due to Renal CausesClinicalTrials.gov · fetched Nov 12, 2026
- CholecalciferolSecondary Hyperparathyroidism Due to Renal CausesClinicalTrials.gov · fetched Nov 12, 2026
- Measurement of four prostate-specific kallikreins for the 4Kscore Test when serum stored uncentrifugedProstate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Paricalcitol Oral CapsuleSecondary Hyperparathyroidism Due to Renal CausesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric ParticipantsPHASE2 · RECRUITING · started Aug 5, 2026ClinicalTrials.gov NCT07494045 · fetched Nov 12, 2026
- Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH ParticipantsPHASE1_PHASE2 · RECRUITING · started Jul 24, 2026ClinicalTrials.gov NCT07512427 · fetched Nov 12, 2026
- Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary HyperparathyroidismPHASE3 · TERMINATED · started Jan 31, 2023ClinicalTrials.gov NCT05543928 · fetched Nov 12, 2026
- Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19PHASE2 · COMPLETED · started Nov 2, 2020ClinicalTrials.gov NCT04551911 · fetched Nov 12, 2026
- A Clinical Study Investigating the Comparability of Somatrogon in Two Different Drug Product PresentationsPHASE1 · COMPLETED · started Jan 18, 2019ClinicalTrials.gov NCT03810664 · fetched Nov 12, 2026
- Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy SubjectsPHASE1 · COMPLETED · started Aug 20, 2018ClinicalTrials.gov NCT03660800 · fetched Nov 12, 2026
- Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDIPHASE2 · TERMINATED · started Jul 9, 2018ClinicalTrials.gov NCT03602261 · fetched Nov 12, 2026
- Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D InsufficiencyPHASE4 · COMPLETED · started Jun 8, 2018ClinicalTrials.gov NCT03588884 · fetched Nov 12, 2026
- Effects and Safety of OPK-88003 Dose Escalation in Type 2 Diabetes SubjectsPHASE2 · COMPLETED · started Apr 2, 2018ClinicalTrials.gov NCT03406377 · fetched Nov 12, 2026
- Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)PHASE2 · TERMINATED · started Feb 21, 2018ClinicalTrials.gov NCT03297398 · fetched Nov 12, 2026
- 4Kscore Using Serum Stored UncentrifugedCOMPLETED · started Oct 4, 2017ClinicalTrials.gov NCT04130776 · fetched Nov 12, 2026
- Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient ChildrenPHASE3 · COMPLETED · started Dec 1, 2016ClinicalTrials.gov NCT02968004 · fetched Nov 12, 2026
- A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or BPHASE1 · COMPLETED · started May 1, 2015ClinicalTrials.gov NCT02418793 · fetched Nov 12, 2026
- Pharmacokinetics and Pharmacodynamics of Long Acting Human Growth Hormone (hGH) Product (MOD-4023) in Healthy Caucasian and Japanese VolunteersPHASE1 · COMPLETED · started Jan 1, 2015ClinicalTrials.gov NCT02418767 · fetched Nov 12, 2026
- Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic AcidPHASE1 · COMPLETED · started Dec 1, 2014ClinicalTrials.gov NCT02274623 · fetched Nov 12, 2026
- A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 DiabetesPHASE2 · COMPLETED · started Apr 1, 2014ClinicalTrials.gov NCT02119819 · fetched Nov 12, 2026
- Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient ChildrenPHASE2 · COMPLETED · started Feb 1, 2014ClinicalTrials.gov NCT02500316 · fetched Nov 12, 2026
- A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without DementiaPHASE2 · COMPLETED · started Sep 1, 2013ClinicalTrials.gov NCT01791725 · fetched Nov 12, 2026
- A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's DiseasePHASE2 · TERMINATED · started Jan 1, 2013ClinicalTrials.gov NCT01766336 · fetched Nov 12, 2026
- Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's DiseasePHASE2 · COMPLETED · started Nov 1, 2012ClinicalTrials.gov NCT01735630 · fetched Nov 12, 2026
- Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I DisorderPHASE2 · TERMINATED · started Aug 1, 2012ClinicalTrials.gov NCT01674010 · fetched Nov 12, 2026
- ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's DiseasePHASE2 · COMPLETED · started Jun 1, 2009ClinicalTrials.gov NCT00934050 · fetched Nov 12, 2026
- ELND005 in Patients With Mild to Moderate Alzheimer's DiseasePHASE2 · COMPLETED · started Dec 1, 2007ClinicalTrials.gov NCT00568776 · fetched Nov 12, 2026
- A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1PHASE1 · COMPLETED · started Sep 1, 2005ClinicalTrials.gov NCT00239187 · fetched Nov 12, 2026
- A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1PHASE1 · COMPLETED · started Jun 1, 2005ClinicalTrials.gov NCT00239148 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 15, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 2, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 14, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Jul 27, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 27, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 18, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Apr 28, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 28, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 19, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Feb 26, 2026 · fetched Nov 12, 2026